Skip to content
Screener

Accrued Expenses at other companies

TFX
TeleflexTFX
$110.21M-3.5%
Intuitive Surgical logo
Intuitive SurgicalISRG
$425.7M+1.2%
PDE
Pro-Dex, Inc.PDEX
$4.32M+21.9%
Microbot Medical logo
Microbot MedicalMBOT
$2.69M+26.8%
iRadimed logo
iRadimedIRMD
$2.07M-8.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$7.51M-1.2%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.24B-21.2%
Enterprise value$1.31B
P/S3.7×

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemJune 30, 2026December 31, 2025
Accrued compensation20,44323,175
Deferred revenue14,08813,048
Operating lease, current2,5052,214
Other current liabilities12,09110,073
Total current liabilities64,19665,795
Long-term debt51,71551,615
Operating lease, non-current23,28024,654
Other non-current liabilities91147

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's accrued expenses?
PROCEPT BioRobotics Corporation (PRCT) reported accrued expenses of $12.09M in Q2 2026.
How has PROCEPT BioRobotics Corporation's accrued expenses changed year-over-year?
PROCEPT BioRobotics Corporation's accrued expenses increased by 24.7% year-over-year, from $9.69M to $12.09M.
What is the long-term trend for PROCEPT BioRobotics Corporation's accrued expenses?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's accrued expenses has grown at a 38.5% compound annual growth rate (CAGR), from $1.98M to $10.07M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about PROCEPT BioRobotics Corporation's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude